top of page
Search


Urine Dipstick No Longer Recommended: Key UTI Updates for Men
New French guidelines on urinary tract infections (UTIs) in men, presented in 2025 and expected to be published in 2026, bring important changes that also matter for men dealing with urinary symptoms and incontinence. A key shift is that urine dipstick tests are no longer recommended for diagnosing UTIs in men. Instead, doctors should rely on symptoms and urine cultures taken before antibiotics are started. Male cystitis (bladder infection) is now formally recognized as a rea
urologyxy
Jan 11


Frailty as a Predictor of Falls in Older Adults with Type 2 Diabetes
Background: Frailty and falls significantly impact the health and quality of life of older adults with type 2 diabetes (T2D), increasing morbidity and dependency. However, their association in Vietnamese populations remains understudied. This study aimed to examine the association between frailty and fall risk and identify additional fall-related factors among older Vietnamese outpatients with T2D. Methods: A cross-sectional study was conducted among 740 outpatients with T2
urologyxy
Jan 11


Mirabegron Therapy Benefits: A Solution for Overactive Bladder
Overactive bladder (OAB) is a common condition that affects many men, causing frequent urges to urinate, urgency, and sometimes incontinence. Managing these symptoms can be challenging, but advances in medication have brought new hope. One such medication is mirabegron, which offers a different approach to treating OAB. In this article, I will share insights about mirabegron therapy benefits, how it works, and what to expect when using it. Understanding Overactive Bladder and
urologyxy
Jan 5


MPS2-AS Urine Test: Reducing Biopsies in Prostate Cancer Surveillance
A new urine test, MPS2-AS, shows promise for detecting aggressive prostate cancers in men on active surveillance, potentially reducing the need for repeated biopsies. The test is based on the FDA-approved MyProstateScore 2.0 (MPS2) assay and can identify tumors at Grade Group 3 (Gleason 4+3) or higher, the threshold at which treatment is generally recommended. In a study of 223 men undergoing surveillance biopsies, the MPS2-AS test correctly detected 93% of higher-grade tumor
urologyxy
Jan 3


Vanquish Steam Therapy: Promising Focal Treatment for Prostate Cancer
The FDA has granted 510(k) clearance to the Vanquish Water Vapor Ablation System, a new focal therapy that uses steam to destroy prostate cancer tissue. Developed by Francis Medical, the device delivers water vapor directly into prostate tumors via a transurethral approach, releasing thermal energy that destroys cancer cells while aiming to preserve surrounding tissue. Approval was based on early results from the VAPOR 2 study, a prospective, single-arm trial involving 235 me
urologyxy
Jan 3


PSA Screening Linked to Long-Term Reduction in Prostate Cancer Deaths
A large European study with more than 20 years of follow-up shows that PSA blood test screening significantly reduces deaths from prostate cancer. The research is part of the European Randomized Study of Screening for Prostate Cancer (ERSPC), which began in 1993 and included over 160,000 men from eight European countries. This is the longest and most comprehensive prostate cancer screening study to date, and its findings were recently published in The New England Journal of M
urologyxy
Jan 3


Genitourinary Radiation Injury: A Mixed-Methods Study Exploring Patient-Reported Outcomes and Impact on Quality of Life
ABSTRACT Objective To assess the long-term outcomes and lived experiences of patients with genitourinary radiation injuries following prostate cancer radiation therapy. Materials and Methods This mixed-methods study included twenty patients recruited from a high-volume reconstructive urology practice from 2023 to 2025. Participants completed International Prostate Symptom Score (IPSS) and Patient-Reported Outcomes Measurement Information System Sexual Function and Satisfactio
urologyxy
Jan 3


Phenotyping Overactive Bladder-Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI-RS 2025
Abstract Introduction: Overactive bladder (OAB) is defined as urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urgency urinary incontinence (OAB-wet) or without (OAB-dry), in the absence of urinary tract infection or other detectable disease. The key symptom of OAB, urinary urgency, is defined as a complaint of sudden, compelling desire to pass urine which is difficult to defer. However, patients report a range of individual experience
urologyxy
Dec 29, 2025


Assessing physical therapists' knowledge in fall prevention among older adults in Saudi arabia: a cross-sectional study
Abstract Background: Falls among older adults remain a major global health concern, often leading to injury, disability, and loss of independence. Physical therapists are key stakeholders in fall prevention, yet their knowledge, attitudes, and practices remain underexplored in Saudi Arabia. Objectives: This study aimed to assess physical therapists' knowledge, attitudes, and confidence regarding fall prevention strategies for adults aged 65 and above and to identify factors i
urologyxy
Dec 29, 2025


Understanding the Risks of Generic Tacrolimus: A Critical Overview
The Importance of Tacrolimus in Organ Transplantation A recent ProPublica investigation reveals how lax FDA standards for approving generic drugs like tacrolimus can put patients at risk. This is particularly concerning for those relying on precise medications. Tacrolimus is a critical immunosuppressant taken lifelong by organ transplant recipients, including many men, to prevent rejection. Generic versions of tacrolimus were approved under the FDA’s broad bioequivalence ran
urologyxy
Dec 24, 2025


Understanding the Risks of Underrepresentation in Clinical Trials: A Focus on Cancer Medications
The Importance of Diverse Clinical Trials This study examines how the underrepresentation of vulnerable patients in clinical trials may lead to underestimated risks of adverse drug effects, particularly regarding cancer medications. Using data from the Surveillance, Epidemiology, and End Results (SEER) Program linked to Medicare claims, researchers analyzed the relationship between trial participation and drug-induced serious adverse events (SAEs). Increased Hospitalization R
urologyxy
Dec 24, 2025


Understanding the Impact of Private Health Insurers on Healthcare Costs
The Influence of Insurers on Healthcare Private health insurers play a significant role in shaping healthcare costs and utilization in the U.S. However, research on their specific impact, especially regarding chronic conditions, has been limited. This study explores how changes in insurance can affect spending patterns. Methodology of the Study This study employs natural experiments derived from hundreds of employer switches between primary insurers. It uses a movers design t
urologyxy
Dec 24, 2025


Impact of Roommate Cognitive Health on Nursing Home Mortality: Evidence of Peer Effects
This study investigates how patient peer effects in nursing homes influence mortality, using administrative data from 2.6 million stays across 7,200 U.S. facilities between 2000 and 2010. By leveraging exogenous roommate assignments through unique room identifiers, the researchers found that patients placed with roommates diagnosed with Alzheimer’s disease (AD) or Alzheimer’s disease-related dementias (ADRD) faced a 2.1 percentage point higher 90-day mortality rate compared t
urologyxy
Dec 24, 2025


Metformin Active Surveillance Trial in Low-Risk Prostate Cancer
Abstract Purpose Active surveillance (AS) is a standard management strategy for low-risk prostate cancer (PCa), but a significant proportion of patients ultimately experience disease progression. Metformin, a commonly prescribed antidiabetic agent, has demonstrated antitumor activity in preclinical studies and observational data, prompting investigation into its potential to delay PCa progression. Patients and Methods The Metformin Active Surveillance Trial (MAST) was a multi
urologyxy
Dec 24, 2025


Preventable Tragedies: Improving NHS Care for Men with Learning Disabilities
A recent ITV News investigation highlights severe failings in NHS care for people with learning disabilities, particularly men, which have led to avoidable deaths. The report focuses on cases such as Adrian Poulton, a 56-year-old man with Down syndrome, who died after being starved for nine days in hospital due to miscommunication and staff errors. Families expressed shock, stating he repeatedly communicated fear of dying, yet received no nutrition during his admission. These
urologyxy
Dec 24, 2025


Powerful Hospitals, Poor Health: The Albany, Georgia Story
ProPublica’s Sick in a Hospital Town explores how Phoebe Putney Memorial Hospital , the dominant health institution in Albany, Georgia, reflects the strengths and faults of the U.S. health care system. Albany is a small, predominantly Black and low‑income city plagued by some of the nation’s highest rates of chronic illness long before COVID‑19 struck. Despite being home to a large, influential hospital system, residents suffer from heart disease, kidney disease, diabetes, a
urologyxy
Dec 24, 2025


New Prostate Cancer Screening Guidance: What Men Should Know
The UK National Screening Committee (UK NSC) has opened a public consultation on updated prostate cancer screening recommendations, reflecting new evidence and modelling studies. Prostate cancer is the most common cancer in men in the UK, causing about 12,000 deaths annually, primarily in men over 75. Screening decisions must balance benefits against harms, including false positives, overtreatment, and treatment-related side effects such as urinary incontinence and erectile d
urologyxy
Dec 24, 2025


Preventing Falls in Older Men Using Wheelchairs or Scooters: The iROLL Program
A recent study highlights the benefits of an online fall-prevention program for older men who rely on wheelchairs or scooters. Falls are a significant risk for elderly men with mobility limitations, including those living with conditions like multiple sclerosis (MS). Each year, about one in four older adults experience falls, which can lead to injury, loss of confidence, and reduced participation in community life. Researchers at the University of Illinois Urbana-Champaign te
urologyxy
Dec 24, 2025


Better Care, Shorter Waits: Fixing Hospital Funding for Men’s Health
Australian public hospitals are spending more each year, yet many patients still face long waits, overcrowded emergency departments, and delayed procedures. A new report highlights that around $1.2 billion annually is wasted on avoidable hospital costs that do not improve patient care. If managed better, this money could fund 160,000 additional hospital visits each year , easing pressure on the system. For men with urinary health conditions—such as prostate disease, incontin
urologyxy
Dec 24, 2025


Why Stronger NDIS Penalties Alone Won’t Fix Provider Accountability
The Australian government has announced some of the toughest penalties in the history of the National Disability Insurance Scheme (NDIS), including fines of up to $16.5 million and potential jail time for serious breaches. These reforms aim to address fraud, neglect, violence, and misuse of participant funds. However, their impact is limited by a major structural problem: around 94 per cent of NDIS providers remain unregistered and therefore fall outside formal regulatory ove
Teodora Gjorgieva
Dec 24, 2025
bottom of page